Neutral
Phathom Pharmaceuticals (PHAT) Loss Compression Challenges Bearish Narratives After Q1 2026 Results
Phathom Pharmaceuticals (PHAT) released its Q1 2026 results, reporting $57.6 million in revenue and a significant reduction in EPS loss to $0.29. The ...